Personal tools

MCL coexpression mm9:815: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 6: Line 6:
|ontology_enrichment_disease=
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0001135!5.18e-14!3;UBERON:0004237!5.18e-14!3;UBERON:0004695!5.18e-14!3;UBERON:0002111!5.18e-14!3;UBERON:0004178!5.18e-14!3;UBERON:0001134!6.45e-12!9;UBERON:0002036!6.45e-12!9;UBERON:0002385!6.45e-12!9;UBERON:0000486!6.45e-12!9;UBERON:0007503!6.45e-12!9;UBERON:0001015!6.45e-12!9;UBERON:0002329!6.45e-12!9;UBERON:0003082!6.45e-12!9;UBERON:0003059!6.45e-12!9;UBERON:0007282!6.45e-12!9;UBERON:0004290!6.45e-12!9;UBERON:0009618!6.45e-12!9;UBERON:0000383!1.06e-10!10;UBERON:0000947!1.26e-10!4;UBERON:0001637!1.26e-10!4;UBERON:0004573!1.26e-10!4;UBERON:0003509!1.26e-10!4;UBERON:0004571!1.26e-10!4;UBERON:0010191!1.26e-10!4;UBERON:0004572!1.26e-10!4;UBERON:0007524!1.05e-09!11;UBERON:0003077!1.05e-09!11;UBERON:0007285!1.05e-09!11;UBERON:0000055!1.39e-08!5;UBERON:0007500!1.39e-08!5;UBERON:0001981!1.39e-08!5;UBERON:0002049!1.39e-08!5;UBERON:0007798!1.39e-08!5;UBERON:0004537!1.39e-08!5;UBERON:0006965!1.39e-08!5
|ontology_enrichment_uberon=UBERON:0001135!5.18e-14!3;UBERON:0004237!5.18e-14!3;UBERON:0004695!5.18e-14!3;UBERON:0002111!5.18e-14!3;UBERON:0004178!5.18e-14!3;UBERON:0001134!6.45e-12!9;UBERON:0002036!6.45e-12!9;UBERON:0002385!6.45e-12!9;UBERON:0000486!6.45e-12!9;UBERON:0007503!6.45e-12!9;UBERON:0001015!6.45e-12!9;UBERON:0002329!6.45e-12!9;UBERON:0003082!6.45e-12!9;UBERON:0003059!6.45e-12!9;UBERON:0007282!6.45e-12!9;UBERON:0004290!6.45e-12!9;UBERON:0009618!6.45e-12!9;UBERON:0000383!1.06e-10!10;UBERON:0000947!1.26e-10!4;UBERON:0001637!1.26e-10!4;UBERON:0004573!1.26e-10!4;UBERON:0003509!1.26e-10!4;UBERON:0004571!1.26e-10!4;UBERON:0010191!1.26e-10!4;UBERON:0004572!1.26e-10!4;UBERON:0007524!1.05e-09!11;UBERON:0003077!1.05e-09!11;UBERON:0007285!1.05e-09!11;UBERON:0000055!1.39e-08!5;UBERON:0007500!1.39e-08!5;UBERON:0001981!1.39e-08!5;UBERON:0002049!1.39e-08!5;UBERON:0007798!1.39e-08!5;UBERON:0004537!1.39e-08!5;UBERON:0006965!1.39e-08!5
|tfbs_overrepresentation_for_novel_motifs=0.354643,0.227469,0.330161,1.02163,0.227651,1.05171,0.495658,0.448965,0.468136,0.314043,0.453212,0.484001,0.449446,0.507558,1.26184,0,0.696644,0.22065,0.419123,0.247067,0.296085,0.179861,0.50668,1.20034,0.337218,0.534339,0.402559,0.428336,0.268347,0.656973,0.414842,0.796599,1.17111,0.364174,0.242923,8.387,0.210533,0.480503,0.191662,8.45322,0.637027,0.419787,0.663794,0.244285,0.158271,0.383899,0.618203,0.443479,0.314152,0.271021,0.679429,0.560572,0.30602,0.937018,0.954342,0.514504,2.14467,0.471658,0.384731,0.512521,0.776777,0.569793,0.163832,0.668331,0.525334,0.708248,1.08987,1.43807,0.772155,1.29123,0.31262,0.900535,0.191038,0.987652,0.116281,0.107966,0.735293,0.607043,0.759798,0.299972,0.463363,0.713779,0.568383,0.436063,0.873141,0.0176817,0.0211263,1.61229,0.623015,1.60001,1.15927,0.878077,0.809272,0.232894,0.551605,0.515495,0.444003,0.812053,0.618454,0.0816605,0.605162,0.796322,0.919715,0.680015,0.678976,0.419366,0.737915,0.439611,0.30446,0.297733,0.348012,0.921485,0.301014,0.458194,1.16629,0.222515,0.265919,0.398075,0.697928,0.597328,0.993019,0.647706,0.536114,0.606154,1.22022,0.763454,0.503569,0.802564,1.08836,0.235546,0.90286,0.387557,1.05894,0.527782,1.18781,3.21543,0.362565,0.421136,1.13883,1.96797,1.5682,1.09456,0.547855,0.806961,0.672593,0.420221,0.621266,1.92834,0.364791,0.229209,0.32395,0.161645,0.938577,0.178329,0.526881,1.01974,0.561556,0.253271,0.352329,0.362302,1.1483,0.872292,0.763895,0.914544,0.669337,0.519673,1.77857,0.482466,0.254444
}}
}}

Revision as of 18:57, 26 November 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr13:115246787..115246797,-p@chr13:115246787..115246797
-
Mm9::chr15:62082108..62082111,+p@chr15:62082108..62082111
+
Mm9::chr1:166561874..166561885,+p@chr1:166561874..166561885
+
Mm9::chr2:178190105..178190122,+p@chr2:178190105..178190122
+
Mm9::chr4:124799704..124799713,-p4@Zc3h12a
Mm9::chr4:145000183..145000220,+p1@ENSMUST00000150529
Mm9::chr8:33120000..33120013,-p5@Nrg1
Mm9::chr9:50913937..50913956,-p@chr9:50913937..50913956
-
Mm9::chr9:50913979..50913993,-p@chr9:50913979..50913993
-


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


GO IDGO nameFDR corrected p-value
GO:0005176ErbB-2 class receptor binding0.0120528132361804
GO:0046579positive regulation of Ras protein signal transduction0.0120528132361804
GO:0045213neurotransmitter receptor metabolic process0.0120528132361804
GO:0051057positive regulation of small GTPase mediated signal transduction0.0120528132361804
GO:0043624cellular protein complex disassembly0.0120528132361804
GO:0043241protein complex disassembly0.0120528132361804
GO:0032984macromolecular complex disassembly0.0120528132361804
GO:0007416synaptogenesis0.0125550137876879
GO:0048663neuron fate commitment0.0125550137876879
GO:0022411cellular component disassembly0.0125550137876879
GO:0007422peripheral nervous system development0.0125550137876879
GO:0043112receptor metabolic process0.0125550137876879
GO:0010001glial cell differentiation0.0176156501144174
GO:0042063gliogenesis0.0176487622386927
GO:0050808synapse organization and biogenesis0.0176774594130645
GO:0045860positive regulation of protein kinase activity0.028697174371858
GO:0033674positive regulation of kinase activity0.028697174371858
GO:0051347positive regulation of transferase activity0.028697174371858
GO:0043062extracellular structure organization and biogenesis0.028697174371858
GO:0046578regulation of Ras protein signal transduction0.028697174371858
GO:0045165cell fate commitment0.028697174371858
GO:0000165MAPKKK cascade0.0292711178592952
GO:0051056regulation of small GTPase mediated signal transduction0.0292711178592952
GO:0045859regulation of protein kinase activity0.0292711178592952
GO:0043549regulation of kinase activity0.0292711178592952
GO:0043085positive regulation of catalytic activity0.0292711178592952
GO:0051338regulation of transferase activity0.0292711178592952
GO:0003712transcription cofactor activity0.0292711178592952
GO:0007265Ras protein signal transduction0.0307346737522599
GO:0045595regulation of cell differentiation0.0307346737522599
GO:0007517muscle development0.0320152851586041
GO:0007507heart development0.0320152851586041
GO:0008134transcription factor binding0.0336769781599157
GO:0007268synaptic transmission0.0336769781599157
GO:0007626locomotory behavior0.0347809753386919
GO:0005125cytokine activity0.0356698121449121
GO:0007243protein kinase cascade0.0356698121449121
GO:0019226transmission of nerve impulse0.0356826707650076
GO:0016481negative regulation of transcription0.0367765326950119
GO:0045934negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process0.0370350079438996
GO:0050793regulation of developmental process0.0370350079438996
GO:0050790regulation of catalytic activity0.0370350079438996
GO:0016477cell migration0.0370350079438996
GO:0030182neuron differentiation0.0370350079438996
GO:0031324negative regulation of cellular metabolic process0.0370350079438996
GO:0065009regulation of a molecular function0.0370350079438996
GO:0007610behavior0.0370350079438996
GO:0048699generation of neurons0.0370350079438996
GO:0051674localization of cell0.0370350079438996
GO:0006928cell motility0.0370350079438996
GO:0007267cell-cell signaling0.0370350079438996
GO:0009892negative regulation of metabolic process0.0370350079438996
GO:0009966regulation of signal transduction0.0370350079438996
GO:0007264small GTPase mediated signal transduction0.0370350079438996
GO:0022008neurogenesis0.0370350079438996
GO:0009790embryonic development0.047795638695198
GO:0000902cell morphogenesis0.047795638695198
GO:0032989cellular structure morphogenesis0.047795638695198



Relative expression of the co-expression cluster over median <br>Analyst:





Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>


Uber Anatomy
Ontology termp-valuen
smooth muscle tissue5.18e-143
blood vessel smooth muscle5.18e-143
arterial system smooth muscle5.18e-143
artery smooth muscle tissue5.18e-143
aorta smooth muscle tissue5.18e-143
skeletal muscle tissue6.45e-129
striated muscle tissue6.45e-129
muscle tissue6.45e-129
multilaminar epithelium6.45e-129
epithelial vesicle6.45e-129
musculature6.45e-129
somite6.45e-129
myotome6.45e-129
presomitic mesoderm6.45e-129
presumptive segmental plate6.45e-129
dermomyotome6.45e-129
trunk paraxial mesoderm6.45e-129
musculature of body1.06e-1010
aorta1.26e-104
artery1.26e-104
systemic artery1.26e-104
arterial blood vessel1.26e-104
systemic arterial system1.26e-104
aortic system1.26e-104
arterial system1.26e-104
dense mesenchyme tissue1.05e-0911
paraxial mesoderm1.05e-0911
presumptive paraxial mesoderm1.05e-0911
vessel1.39e-085
epithelial tube open at both ends1.39e-085
blood vessel1.39e-085
vasculature1.39e-085
vascular system1.39e-085
blood vasculature1.39e-085
vascular cord1.39e-085


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}